Mopral (Omeprazole)

Omeprazole, the active ingredient in Mopral, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid production and is employed in the management of acid‑related gastrointestinal disorders in adult patients, with a well‑established safety profile.

GNH USA supplies Mopral as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution, ensuring product integrity from manufacturing to delivery.

Omeprazole is a proton pump inhibitor used to manage conditions related to excess gastric acid. - Gastro‑esophageal reflux disease (GERD): relief of heartburn and prevention of esophageal damage. - Peptic ulcer disease: promotes healing of gastric and duodenal ulcers. - Helicobacter pylori eradication regimens: enhances effectiveness of antibiotic combinations. - Erosive esophagitis: reduces inflammation and promotes mucosal healing.

Adverse reactions may occur with omeprazole therapy.

Common Side Effects: - Headache: mild to moderate head pain. - Abdominal pain: discomfort in the stomach area. - Nausea: feeling of sickness. - Diarrhea: loose stools.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Clostridioides difficile‑associated colitis: severe intestinal infection. - Hypomagnesemia: low blood magnesium that may cause muscle cramps or cardiac issues.

Before initiating therapy, consider the following precautions. - Assess renal function: dose may need adjustment in severe impairment. - Avoid long‑term use without supervision: risk of nutrient malabsorption. - Monitor for signs of infection: especially C. difficile. - Use cautiously in patients with osteoporosis: prolonged therapy may affect bone density. - Store at ambient temperature: keep in original container, protect from moisture and light.

Omeprazole may interact with several medicines; categorize them by clinical significance.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased absorption of antiretroviral. - Methotrexate (high dose): increased toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: may enhance anticoagulant effect. - Digoxin: possible increased serum levels. - Diazepam: may increase sedation.